Does ELAFIBRANOR Cause Product dose omission issue? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Product dose omission issue have been filed in association with ELAFIBRANOR (IQIRVO). This represents 7.6% of all adverse event reports for ELAFIBRANOR.
27
Reports of Product dose omission issue with ELAFIBRANOR
7.6%
of all ELAFIBRANOR reports
1
Deaths
5
Hospitalizations
How Dangerous Is Product dose omission issue From ELAFIBRANOR?
Of the 27 reports, 1 (3.7%) resulted in death, 5 (18.5%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELAFIBRANOR. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does ELAFIBRANOR Cause?
Fatigue (45)
Pruritus (34)
Constipation (33)
Nausea (30)
Weight increased (26)
Myalgia (25)
Diarrhoea (24)
Arthralgia (21)
Dizziness (17)
Muscle spasms (16)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ELAFIBRANOR Alternatives Have Lower Product dose omission issue Risk?
ELAFIBRANOR vs ELAGOLIX
ELAFIBRANOR vs ELAGOLIX\ESTRADIOL\NORETHINDRONE
ELAFIBRANOR vs ELAPEGADEMASE-LVLR
ELAFIBRANOR vs ELASOMERAN
ELAFIBRANOR vs ELBASVIR